Add your company website/link
to this blog page for only $40 Purchase now!Continue
FutureStarrKing Soulja - Mask On Official Music Video
Earlier this year, King Soulja released an official music video for his song, "Mask On." The video shows King Soulja wearing a mask in a shady alley. The video also features Method Man and Redman as they spit freestyles. The video is a must-see for fans of both artists.
XXXTentacion was a phenom and his legacy will live on through his music. The South Florida hip-hop collective Members Only has released the third installment in the group's collaboration series. Featuring artists like Killstation, Kin$oul, Robb Bank$, XXXTentacion, Wifisfuneral, and more, the album encapsulates the South Florida music scene with ease.
The album is the first in the series to be released as an album. It was released on June 26th via SoundCloud. The album was released on Record Store Day, a day strictly dedicated to limited edition releases. The album is accompanied by a red and black splatter vinyl. The album is a showcase of the group's growth and a testament to XXXTentacion's legacy.
The album has some big names, but it's the smaller details that will have fans singing its praises long after the album's release date has passed. In addition to the album's most notable tracks, there are plenty of other songs worth listening to. The album includes songs with a variety of clever wordplay. The album's best tracks include "The Man of the Woods" by Kid Trunks and "DisDaHateSongBby :/" by Wifisfuneral. The album is definitely worth a listen, especially if you are into South Florida music.
XXXTentacion Presents: Soulja World is the latest installment in his Members Only series. This latest release features an edited version of Mario & Luigi: Superstar Saga's "Joke's End". In addition to the track, XXXTentacion also featured guest appearances from Beyonce, Drake, Young L, and Ski Mask the Slump God. The album also features a music video for the song "Look" featuring Lyrical Lemonade.
The album is executive produced by Soulja Boy, Travis Scott, and Future. It also features appearances from other hip-hop artists such as Kanye West, Kid Cudi, and Ski Mask the Slump God. XXXTentacion has also appeared on several other projects including Westside Boogie's MORE BLACK SUPERHEROES, Kanye West's Donda 2, and Westside Boogie's MORE BLACK SUNSHIRES.
The album includes a number of references to Mario, such as the track "Triple Chain Gang" and the song "Bowser" from "Members Only, Vol. 3". In addition to the song's title, "Bowser" also features a number of pop culture references. In addition to the song's title, the track also includes a number of 808s and Lyrical Lemonade's music video.
The track has reached the first lines of the charts. As a result, it has been used by Beyonce in her hit song "Turn My Swag On" (2008).
Anime music videos have become a staple at anime conventions in Western countries. They are a mix of lip sync performance and footage from other anime works. They are also a mix of re-editing and adding new soundtracks.
Anime music videos can be a fun and exciting experience for fans of Japanese pop culture. As a result, the Gokuraku Jodo in King Soulja's Mask on Official Music Video is sure to be a hit amongst fans of Japanese music. The video was released on July 28, 2016 and received a whopping 63 million views on YouTube as of 27 June 2020. The Gokuraku Jodo is a J-pop song by Japanese pop duo Garnidelia. The song is also featured in Wu Li Wu Xian. It has been described as a reimagining of the 1980s song of the same name.
The Gokuraku Jodo in King Soulja's Mask on Official Music Video is not the only awe-inspiring video that has been released on the aforementioned site. The site also hosted the Just Dance event on August 16, 2022.
During the event of It's Everyday Bro Day Bro, many YouTube rips were uploaded to the channel. These rips are referencing the song and the video game. For instance, a French DJ named Tchami has entered a level heavily based on Super Mario World. There are also many references to video games in the official music video.
The song was released on 31 March. The video has over 690 million views on YouTube. The video also reached Billboard Hot 100. The song's lyrics reference Get Out, Jim Crow, the 2015 Charleston Church massacre, and minstrel shows. The song also references the book of Revalation, a fictional book that talks about the state of America.
The song features hip hop producer DJ Scheme and Danny Towers. The song also samples the song "Haunted Chase" from Donkey Kong Country 2. The song also references the video game Super Mario World 2: Yoshi Island. The song also features Ski Mask the Slump God. The song is also based on a Spanish song by a Mexican group.
The video has become a popular prank. It has also been featured on The Colbert Report. The song has also been remixed by many internet users. The video was released as a response to T-Series becoming the most subscribed YouTube channel. The song reached number one on the Billboard Hot 100.
Def Jam Records is the official home of the aforementioned duo, who are also known as Method Man and Redman. The two have been working together since 1994, releasing their Blackout! album in 1999. They have since released the sequel in 2009, and are currently on tour. Ahead of the tour, they recently performed at BB King's in New York City. Among the acts that appeared were Snoop Dogg and Young Dirty Bastard.
The official music video of the aforementioned song features the duo in a suitably Halloween-themed getup. The silver hockey mask on the side of their heads may be the only thing that resembles a mask, but the two rappers have clearly taken a page out of the book of horror films. For their performance, the duo wore masks a la horror movie icons such as Freddy Krueger and Jason Voorhees. Their performance was a hit, attracting hundreds of fans. The pair also showed off the best of the rap swagger with a performance that included the other members of the Wu-Tang Clan. This performance was a big moment in Method Man's career, as it was the first time that he had performed with his fellow hip hop legends.
Unless you've been under a rock, you've heard of the We Are Born to Play music video. This is the best music video by a long shot. Besides starring the sultry Soulja Boy, the film also features the likes of Lil' Kim, Aaliyah, and a slew of other hip hop luminaries. Although the film did not come out until January 2019, the star-studded cast is set to perform at a slew of upcoming festivals and shows. The star-studded cast has a knack for performing in front of large crowds and making a splash on the festival scene. One of the performers, Soulja Boy, has been showcasing his musical skills since the early 2000s. You can see him in action by visiting his YouTube channel. Among the highlights of his performance are his signature dance moves, a song titled Crank That, and the aforementioned ode to Lil' Kim.
Throughout his career, Eminem has had the ability to create songs that are easy to understand and listen to. This was the case when he released his Slim Shady LP. It was a success, and helped to launch his career. Now, he has released a freestyle that is as funny as it is musical. He complains about condoms, Lubriderm, and Daffy Duck. He also hits his mom with an omelet.
In his freestyle, Eminem also talks about his career as a rapper, revealing some of the criticism he's faced. He cites some of his biggest successes, like his "Beamer, Benz, or Bentley" sample from Lloyd Banks' "Beamer, Benz, or Benz". He also dishes back some criticism, saying, "I'm gonna give ya what you want, so get used to it." He also mentions his success in the music industry, and how he could have become a hit if he had focused more on music.
Whether you are a Nets fan or a Los Angeles Lakers fan, this game is one you cannot afford to miss. The Brooklyn Nets will be playing the Los Angeles Lakers at the Staples Center, Saturday night, November 1.
Unlike some of his more illustrious predecessors, Jordan Hill is not the prototypical center. While he is an athletic and fast guy, his greatest asset is his lateral mobility. That's something that's not matched by many centers. That's not to say he's bad at protecting the paint, but he's not great at it.
While his per 36 minute average is not quite the gaudy number it was last season, he's still been averaging over 21 minutes a night. He's also had some big games, such as his 62 point performance in the Dallas Mavericks' loss to the Phoenix Suns. He's a legit post scorer, and he can play for a team like the Pelicans, which may be looking to trade for Marcin Gortat.
The Pelicans may have a plethora of big men on the roster, but they still need a solid inside presence to complement Anthony Davis and Nikola Vucevic. Jordan Hill is the man. He's a big and strong center with an uncanny ability to execute put-backs. His lateral mobility is not matched by many centers, and his opponents' FG% at the rim was among the top half of 91 players.
The big question is how much will Jordan Hill actually cost? The Lakers are unlikely to resign him this season, but it's certainly not impossible. If they do, he'll have to sign a deal worth at least $18 million. That's a lot of money for a guy who turns 27 in July. He's not the biggest name in town, and he's probably not the best center on the market, but he's got the wits to make his case.
The most important question is what's the best way to make sure he gets that money. While he may not be the best player in the league, he's a savvy player with a proven track record. If he proves he can stay healthy, he can be a bargain for a team looking to rebuild. He's a dependable rebounder, and his lateral mobility is something that many centers can't match. He's also a smart guy, and he's not afraid to mix it up in the middle.
During the first game of the 2010 NBA Playoffs, Kevin Garnett was quiet but effective for the Brooklyn Nets. He tallied four points on 2-of-5 shooting and added nine rebounds.
In addition to scoring and rebounding, Garnett was active on defense, using veteran savvy to stop shots. He also got to the free throw line four times. He also had two blocked shots.
The Lakers' bench scored 52 points against Brooklyn. Mason Plumlee scored six points and added four rebounds. Nick Young led the Lakers with 26 points. Joe Johnson and Alan Anderson also contributed.
Brooklyn Nets fans might have been surprised that Garnett is still playing. He hasn't made the postseason in the last three years in Minnesota. He's played in 15 All-Star Games, won an NBA MVP award and earned a spot on the All-NBA team nine times. However, he has only one championship ring. He is also in the inner circle of the NBA Hall of Fame.
Garnett spent the first twelve seasons of his NBA career with the Minnesota Timberwolves. He led the team to eight consecutive playoff appearances and helped them reach the Western Conference Finals. However, they lost six straight first-round games. They ended up with an eighth-seed and 25-25 record.
The Timberwolves made several key acquisitions in the 2003-04 season. Terrell Brandon, an NBA veteran, played with Garnett and Wally Sczerbiak. He also helped Garnett lead the team to a franchise record 50-32 record. The Timberwolves limped into the eighth-seed with a 25-25 record.
Garnett's next season was one of his best. He averaged 20.8 points and 10.4 rebounds per game. He also dished out 4.3 assists per game. He also recorded 1.6 blocks and 1.2 steals per game. He earned a second All-NBA first-team nomination.
Garnett's message swung the Celtics' point of view. They were able to win the next three games. But their run was the best comeback in NBA history. They defeated Miami Heat 4-3 in Game 6 and 7. They then defeated the Philadelphia 76ers in a seven-game series.
Kevin Garnett has been a dynamo in the postseason. He has won the NBA MVP and Finals MVP, and he has one championship ring. He has also won seven All-Star Games and is a member of the NBA's All-Defensive Team.
Having played for a number of teams, including the Los Angeles Lakers, Shaun Livingston is no stranger to the spotlight. However, the former fourth overall pick in the 2004 NBA draft had some rough patches in his career. He was injured and was unable to play for the entire 2007-08 season, to name a few.
Despite this, Livingston was a good player in his time with the Los Angeles Clippers. He averaged 16. points and four assists in three starts against the Rockets. He also played a valuable role in Pierce's quest to reach the Eastern Conference semifinals.
Shaun Livingston was an athletic player who could defend wings and guards. He was also a great rebounder. He also had a midrange shot, which was his signature move. However, he wasn't one of the best three-point shooters in the league. In fact, Livingston only shot 20 percent from the long-range.
He also had a strong season in his first year in Golden State, averaging 5.9 points and 3.3 assists per game. He also hit over 48 percent of his shots, which was one of his best seasons.
The Warriors needed a backup point guard, and they signed Shaun Livingston in the summer of 2014. He was given a three-year, $16 million contract. He was also given the chance to start in late November when Deron Williams went down with an ankle sprain.
Shaun Livingston was a big part of the Warriors' run to the NBA Finals. He played a part in all five of the team's postseason appearances, including Game 5 against the Cavaliers, where he scored 10 points off the bench. He also played a crucial role in the team's 67 wins.
Despite the fact that Shaun Livingston has had some disappointing seasons in his career, he still had a good role with the Brooklyn Nets this season. He played well, averaging a career high in points and rebounds. He played 27.2 minutes per game. He also benefited from some bench unit coaching from Luke Walton.
Despite his injuries, Livingston has been one of the best backup point guards in the NBA. He has played for nine teams in his career, including the Clippers, Washington Wizards, Cleveland Cavaliers, and Oklahoma City Thunder. He also spent time in the D-League.
Despite a valiant effort in the fourth quarter, the Brooklyn Nets could not overcome the Los Angeles Lakers in a 99-94 loss at Barclays Center. The Nets have lost three of four games and are still 4-11. A game like this may have led Jason Kidd to reconsider his rotation. But they have a tough road trip to Houston and Memphis. And they'll have to face Steve Nash, who's out due to nerve root irritation.
The Lakers' bench scored 52 points against Brooklyn. Nick Young led the way with 26 points, while Pau Gasol had a big night with 21 points. Mirza Teletovic had 14 points in the fourth quarter. He added two blocks and a steal. Shaun Livingston and Robert Sacré each contributed one rebound. Shaun Livingston had five points, but didn't commit any turnovers. He finished with eight minutes of action. Robert Sacre played eight minutes. Alan Anderson, Tyshawn Taylor, and David West also played significant minutes off the bench.
After a sluggish first quarter, the Nets stormed back in the second quarter with a 15-0 run. They tied the game at 92 with less than four minutes left. The Lakers had a barrage of three-pointers, but the Nets tied the game with nine seconds to go.
During their first game of the season, the Golden State Warriors defeated the Sacramento Kings 126-114 in a battle of two of the top teams in the NBA. Korie Thompson led the Warriors with 37 points, while Sacramento's Derrick Rose also had a strong game, scoring 19 points.
Earlier tonight, the Golden State Warriors extended their winning streak to eight games with a 126-114 win over the Sacramento Kings. The Warriors are 40-13 overall and just two games behind the second-place Phoenix Suns in the Western Conference standings. This is their longest current winning streak.
The Warriors came out on top in the first quarter and scored 26 points at one point. The Warriors shot 56.0% from the field and outrebounded the Kings by 20 points. Golden State shot 20-plus threes for the sixth time this season. The Warriors bench scored a season-high 55 points in the second half. The Warriors were able to hold Sacramento to a season-low 48.8% shooting and outrebounded the Kings by 16. A red herring comeback by Sacramento cut the lead to six points in the fourth quarter, but Golden State was able to pull away.
Damian Jones scored a career-high 17 points, while Davion Mitchell recorded his fifth straight double-double. Jones and Mitchell scored 80% of their points in the first half. The Warriors also got a great game from Jordan Poole, who had 12 points and eight rebounds. Poole got to the free throw line more than any other Warrior.
Klay Thompson had 23 points and made seven 3-pointers. He knocked down three straight from deep early in the second quarter. He also made his initial six 3-pointers. He also finished with seven assists. His 3-pointer with one second left in the third quarter capped a 14-3 run that gave the Warriors a 94-83 lead.
The Warriors' lead grew to 26 points at one point in the fourth quarter, but Sacramento was able to chip away at the lead. Maurice Harkless and Tyrese Haliburton combined for 28 points in the second half. The Kings cut the lead to seven points early in the fourth period, but the Warriors responded with an offensive sequence that sealed the game.
The Warriors had several key players out due to injury, including De'Aaron Fox, Otto Porter Jr. and Marvin Bagley III. But Steph Curry, Klay Thompson, Davion Mitchell, and David Lee each contributed a positive game. The Warriors have won 20 of 27 games against Sacramento this season. And the Warriors have won two of the last three meetings against the Kings.
The Warriors remained hot shooting in the second half, but Sacramento came back in the third quarter to cut the lead to 12 points. A pair of dunks from Mo Harkless and Tyrese Haliburton cut the lead to a single digit, but the Kings were unable to put all their players on the court at once. During garbage time, Harkless and Haliburton combined for seven points.
Sacramento has not won in San Francisco since February of 2020. It's expected that the Warriors will lose next night, but the Kings will have a chance to turn it around against the Oklahoma City Thunder on Saturday.
Despite a sloppy performance in the first half, the Golden State Warriors had no trouble beating the Sacramento Kings on Friday, 122-115. Klay Thompson led the Warriors with 37 points in the third quarter, including a league-record nine three-pointers. It was the first time that a player has scored 37 points in a single quarter in the NBA, and it helped the Warriors erase an early 12 point deficit.
Klay Thompson went 2-for-5 from three-point range in the first half, and the Warriors opened the second half with a 13-2 run that took the lead for good. The Kings cut the lead to three, but the Warriors countered with a flurry of threes. In the fourth quarter, Klay Thompson staked the Warriors to a 97-73 lead by making a pull-up three-pointer at the end of the fast break. He drained two free throws, and then drove from right wing to left side of the key to set up another three-pointer. This was the first time that the Warriors had scored at least 20 points in the fourth quarter since 1994, when they beat the Phoenix Suns, 109-102.
Curry finished with 33 points, and the Warriors made 24 of 47 three-pointers. Stephen Curry led the Warriors with a season-best 15 assists. The Warriors are averaging 53.5 percent shooting, but Golden State has yet to win a game on the road this season. It is the Warriors' first loss on the road since 1989-90.
The Warriors got away with a missed foul on Klay Thompson on the final shot of the game, when Kevin Huerter attempted a three-pointer with 9.8 seconds remaining. Earlier in the game, he made 29 consecutive free throws before missing one in the second quarter. It is unlikely that he will keep this up, however.
The Warriors' bench played well in the second half, outscoring the Kings by 67 points. Klay Thompson and Stephen Curry were both limited in minutes because of elbow soreness. Draymond Green was also limited because of a back injury. The Warriors' bench shot 62.5 percent from the field, while Curry and Thompson were at 53.5 percent.
The Warriors have won seven straight games against the Kings. Golden State has won at least 10 games in each of the last three seasons against Sacramento. It is the longest streak against Sacramento since the Warriors won seven straight in 1994-95. It is also the longest active streak in major U.S. sports.
Sacramento has won three of four games since Michael Malone was fired, but the Kings are still 5-14. They are expected to be in the playoffs, but there are a number of teams ahead of them in the Western Conference. There are also several teams that have a better record. However, there is still a lot of competition in the Western Conference. The Timberwolves and the Los Angeles Clippers lead the Kings by two games, and Portland is also ahead of them.
Defending champions the Golden State Warriors traveled to Sacramento on Friday night to play the Kings. The game was a close one, but the Warriors prevailed 116-113. The Kings had a chance to win the game in the final three minutes, but Buddy Hield missed a desperation three-pointer with five seconds left. This was the first time that Sacramento has failed to win on the Warriors' home floor since Feb. 25, 2020.
The Warriors scored 50 points in the first quarter. This is a record for the quarter. The previous record was held by George Gervin. The Warriors have now won 50 games in eight of the last 10 seasons. They are averaging 12.3 three-pointers per game this season, which is tied with the Brooklyn Nets.
The Warriors led by 12 points at the end of the first quarter. Klay Thompson scored a career-high 52 points, including nine three-pointers in the third quarter. He led the way by tying the record for most 3-pointers made in a quarter. He finished the game with 25 field goal attempts.
The Warriors also held a moment of silence for the victims of the mass shooting at the Route 91 Harvest festival in Las Vegas. They missed the chance to win the game in the closing minutes, but the Kings were also unable to execute their offense down the stretch. They scored only one point in the final 3:50 of the game.
The Warriors have yet to win on the road this season. They are also missing both Klay Thompson and Andre Iguodala. They are also missing the rest of their starting lineup and four of their bench players. Their next game is against Boston, but they are also playing the Lakers on Thursday. They are expected to be without De'Aaron Fox, who is out with a right knee injury.
The Warriors were also without starting point guard Andre Iguodala, who is out for the season. The Kings are also missing forwards Keon Ellis and Patrick Baldwin Jr., as well as center Neemias Queta. It is also possible that the Kings will be without center China Moneke, who is still recovering from back surgery. The Kings also lost Marvin Bagley III for the third straight game due to a left ankle sprain.
The Warriors have won two straight series on the home floor of the Thunder. They have also won two straight series against teams with a LeBron James in them. The Kings also broke a streak of consecutive seasons without a playoff appearance. The Kings were also trying to break a 17-season streak without winning a home game against the Warriors.
In addition to the three-pointer, the Warriors also have a record for most points in a quarter, and have tied the record for most 3-pointers made in a quarter. The Warriors are averaging 12.3 3-pointers per game this season, which is good for fourth in the league.
Having started the season with a win over the Boston Celtics, the Brooklyn Nets have continued to get hot and have a very tough matchup today against the Los Angeles Lakers. Brook Lopez is having a great season and he is leading the Nets in scoring, while Russell Westbrook has been productive off the bench.
Despite the fact that he's not on the Lakers' roster, LeBron James could still sign a new contract for the 2023 NBA Season. A two-year deal could come his way this summer, but he's not in a rush to extend his deal. He's been linked to the Phoenix Suns, who had a solid core last season, but were knocked out of the playoffs in the second round. Getting him to a team that's able to sign his son to a contract, which would make him eligible for the 2024 draft, would be a win-win for both parties.
James is coming off a season in which he averaged 30.3 points, 6.2 assists, and 8.2 rebounds per game. He's also one of the Lakers' best defenders. This could be a great chance for the Lakers to capitalize on their strengths. However, they could also find themselves in a tough situation if they're unable to contain the Golden State Warriors, who have already started off the season with a disappointing record.
The Lakers would be excited to see their star player commit to the franchise. However, they're probably not eager to hand out future first-round picks for the deal. Despite the fact that he's only one year from free agency, James would likely be signed elsewhere by 2023, when his contract ends.
LeBron James is still the best player in the game, even if he's not playing. He's still got the numbers to back up his claim. He needs 1,326 points to pass Kareem Abdul-Jabbar for first place on the all-time scoring list. However, if he misses time, he could jeopardize his record-breaking attempt.
The Lakers would also be happy to see their top player commit to the team before he's eligible to opt out of his contract in the 2024-2025 season. They'd also feel extra motivation to win another championship.
The Lakers may not have been able to improve their roster at the trade deadline, but the team's front office did spend the offseason fixing its mistakes. The Lakers can still build a quality roster for the 2023-24 season.
Despite the fact that Brook Lopez's contract is set to expire next season, it is still unclear how much he will earn in his last season with the Brooklyn Nets. His salary will be roughly $13 million, which isn't too high given that the Nets will need to pay him another $12.7 million when he hits unrestricted free agency.
Brook Lopez has a good basketball IQ, but he is a slow playmaker on rotations. He can get tired playing defense and is not a great rebounder. He also struggles against quicker centers.
Brook Lopez had a solid season. He averaged 16.1 points and 8.1 rebounds per game. He also shot well around the rim, shooting 63.5% on post-ups. His free throw rate was also strong, shooting 80% from the free throw line.
Brook Lopez's shooting isn't as good as it was during his rookie season. He is not a great shooter from the perimeter, but he has improved his passing game this season. He ranks fourth among centers in passing. He also averages over 2.0 assists per game. He ranks fifth in offensive rebounds per game. He also shoots a career-high 2.1 threes per game.
Lopez has great shooting touch and mid-range percentages. He also has a solid basketball IQ and great passing skills. He is a good fit for the Nets' offense, but he needs to improve on defense. He isn't as good a defender as the other stars in the NBA, and his lack of speed can make it harder for him to get to the rim and disrupt opposing shooters.
Brook Lopez has improved his game this season, but he still needs to improve on defense. He has a good position down low, but he has a difficult time defending quicker centers. He has also gotten better at sliding his feet to protect his rim. Ultimately, Brook Lopez is the Nets' best scoring option for the 2023 NBA Season.
Brook Lopez has a good scoring game, but he has a weak offensive rebounding rate. He is below the league average in both categories. He has a below average jump shot, but is also below the league average in lateral movement speed.
Getting Russell Westbrook to play more on the court as part of a second unit has been key for the Los Angeles Lakers. Not only has the former MVP been performing well in that role, he has also shown the ability to be a consummate teammate.
When the Lakers moved Westbrook to the bench last week, he was averaging 10.3 points, 4.3 assists, and 6.7 rebounds on 28.9 percent shooting from the field. The aforementioned numbers have actually increased since the move. In the three games since Westbrook has been on the bench, he has averaged 16.3 points and 46% shooting.
While the Lakers are still searching for the best fit for LeBron James and Anthony Davis, the move may just be the start of the long road back to playoff contention. Getting Russell Westbrook off the bench may just be the right move at the right time.
Since Westbrook has been in the bench, the Lakers have outscored their opponents by 22 over the past 90 minutes. His 6.7 assists and 16.3 points in those three games are also impressive.
Although he has struggled to integrate himself off the ball with LeBron James, Russell Westbrook has been a productive cog in the Lakers' machine. He has also taken some flak from some coaches, but he has shown that he can defy them when the time comes.
Although he has been the subject of trade rumors and speculation since the offseason, the Lakers have yet to make an actual move. The Lakers may be able to buy out Westbrook and keep his rights to Victor Wembanyama, but he has yet to play for his money.
He is the future Hall of Fame point guard, but his role with the Lakers is not yet fully realized. He has been the Lakers' sixth man for the past 15 seasons, and it may be time to get him to play a bigger role.
If he plays well enough in his second unit role, the Lakers may just have found the secret to their success.
Despite being in the same situation as Oklahoma City Thunder, the Detroit Pistons are on the cusp of being a sleeper team in the Play-In Tournament. They've added Markieff Morris and T.J. Warren to a solid roster, and they could even trade for Danny Green and Dillon Brooks if they decide to do so.
Meanwhile, the Boston Celtics and the Los Angeles Clippers are doing just as expected. The Boston Celtics are a great basketball team, and they're probably the best team in the NBA, but they don't have a good enough defensive side of the ball.
The Clippers are a savvy team, and they've got a front office that knows how to take advantage of its players. They're a tough team to play against, and they're able to switch everything from a conventional pick-and-roll defense to an attack in transition. They're also capable of playing a bully ball offense in the half court, and they're able to go five out.
The Portland Trail Blazers are also on the rise, and they're a legitimate threat to make the Play-In Tournament. Their defensive side of the ball is a little weak, but their offense is on fire. Their frontcourt is very deep, and Damian Lillard is back, so they're still a threat.
The Boston Celtics are a great basketball squad, but their small ball lineup needs work on the defensive end. They also have an offensive rating of just over 120, which is the highest in the NBA this season.
The Miami Heat are also doing just as expected. They've won eight straight games, and they're a solid team. But they lost P.J. Tucker, and they're not quite the same team they were last season. They're still a better defensive team than the Lakers, but they're not nearly as good offensively.
The Denver Nuggets have a healthy, hungry team, and they're the two-time defending MVP. They're also the only playoff team from last season that's on the cusp of plummeting. They have eight players who've logged over 1,000 minutes this season.
Despite their great record and recent win streaks, there are several things that concern the Los Angeles Lakers. They have a young star who is injury prone, an injured point guard and a player who has lost some of his confidence.
During the 2018-19 season, LeBron James has had a plethora of injuries. He has missed a number of games due to knee, groin, and foot injuries. However, he is still averaging 29.1 points and 8.8 rebounds per game, while contributing 6.3 assists per game.
LeBron James has been injured for a number of years, but this year's injury is one of the worst of his career. The Lakers have lost four straight games, and have a mediocre record so far in the season. They are also currently without All-NBA big man Anthony Davis, who has missed multiple months due to knee injuries.
James will miss at least a week, if not longer, with the injury. He is expected to undergo tests by the team's medical staff. However, the team has not provided a specific timeline for his return.
The Lakers have a long stretch of off days coming up, so they may have to manage James' load when he is back. Depending on his progress, he may be able to play in his next game against the San Antonio Spurs. However, the Lakers may have to wait until April to see him back on the court.
While the injury isn't as bad as the groin strain James suffered during Christmas, it is still an issue. The Lakers have already missed four games with the injury.
If James is out for an extended period of time, the Lakers will be hard-pressed to win games. The Lakers have the worst offense in the NBA. If James is unable to play, the Lakers will have to rely on Anthony Davis, who averages 29.5 points per game while missing a total of 16 games with injuries. If James is able to play, he will be the Lakers' primary offensive option.
With a lackluster record this season, the Lakers aren't likely to be able to make up the ground they need to make the playoffs. Unless LeBron James starts feeling better, the Lakers could find themselves missing the playoffs again. With this injury, James is already on the wrong side of a streak of three consecutive losing seasons.
During the last few years, Russell Westbrook has not been able to contribute to the Los Angeles Lakers' playoff hopes. He has not been able to find a way to adjust his game to the team's needs. Regardless, he continues to be booed by Laker fans.
When the Lakers traded for Westbrook last summer, they were considered a potential championship contender. They even added him to the team in order to create a dynamic duo with James-Anthony Davis.
However, the Lakers are now eighth in the Western Conference, and they have yet to make the play-in tournament. The Lakers have won only 22 games and lost 23. The Lakers are a team that has been steadily declining. While Russell Westbrook does not play a role that fits the team's needs, the Lakers' other stars have been shooting like flashlights in the dark.
Westbrook had a rough start to the season. He missed three of his first 17 shots, including two wide open jumpers. He missed his second jumper in less than 30 seconds. In the fourth quarter, Westbrook missed a pull-up two-pointer with 18 seconds left. He also had a hard time contributing defensively. The Lakers have been criticized for their inability to stop the shooting of role players.
The Lakers are 0-4 and the criticism is mounting. The Lakers need to win at least one of their two remaining games to qualify for the play-in tournament. However, the Lakers' problems go deeper than Russell Westbrook.
The Lakers' roster is a Frankenstein. While Westbrook has been criticized for his play, the team's other stars are shooting like flashlights in the dark. They are averaging 47.1 million dollars this season.
Westbrook recently opted into the final year of his contract. It is unclear whether he will be back in the Lakers' lineup this season, and the team is likely to lose one of its stars in the offseason. He might also be bothered by a hamstring injury. Regardless, he will not be changing his game.
Westbrook was a future Hall of Famer. He has been selected for the NBA's 75th anniversary team. He is also a member of the FIBA World Championship Team.
During the NBA offseason, the Los Angeles Lakers signed Thomas Bryant and Wenyen Gabriel to two-way contracts. While both players have the potential to be impactful in the NBA, there are a number of questions about how the team plans to use their talents.
In the Lakers' most recent preseason game, Wenyen Gabriel played 24 minutes and scored four points. While he doesn't offer much production, he did do the Lakers a favor by helping the team match up better against a smaller Nets team.
Thomas Bryant played some good basketball during his time in the NBA, but his minutes were not spread out throughout the season. Rather, his minutes were focused during a 27-game stretch near the end of the season. He had a solid impact on the Lakers' offense as a mobile big. He also had B+ grades in ball defense, three-point shooting, and rim protection.
While Wenyen Gabriel's production is not great, he has made some meaningful contributions in the past few games. His experience with LeBron James and Russell Westbrook has served him well. He also can play defense on perimeter players in pick-and-rolls and deflections. He also has a strong midrange game.
He has the potential to become the Lakers' go-to 3-point shooter. But he also has the potential to be overpowered by Nikola Jokic or Steven Adams.
While he isn't the best power forward in the league, he has a solid midrange game and has held his own defensively when miscast as a wing stopper. He also has a high IQ and has been a part of the team's winning formula this season.
He has the potential to be a valuable part of Darvin Ham's offensive scheme. His ability to defend perimeter players in pick-and-rolls will help the Lakers' transition game. He also has the potential to become a win-now player for the Lakers.
Unfortunately, the road to success for the Lakers this season is going to be long and difficult. The Lakers have a lot of questions about their frontcourt rotation. But if they can find a suitor, they could potentially be looking at a trade in the near future.
Throughout his career, Brett Siegel has been involved in the sport of basketball from many different perspectives. Before he began his career with the Los Angeles Lakers, he worked as a sports journalist for the NBA Analysis Network and for Louisville Basketball. He also broke the news of Andre Drummond signing with the Lakers in 2021. In addition, he has also been on the front lines of the NBA draft, breaking the news of the Lakers' picks.
He has worked with future MLB players and served as the head football coach at Saint Bernard High School in Playa del Rey, Calif. He has also been awarded the top sports anchor award by the Southern California Sports Broadcasters Association for thirteen years. Seward has also been recognized for his work with the Los Angeles Daily News as the "Top Sports Update Anchor" for the Los Angeles area.
Schneider is a former television editor at Variety and Daily Variety, as well as a member of the Los Angeles bureau of Electronic Media. He also served as a judge for the Fox Reality Channel's "Reality Challenge." He has covered the tv business for more than 20 years. He has also moderated panels with industry executives and showrunners. Schneider has also launched a website, TV Insider, to provide the industry with the latest news and information. He is the chief content officer for TV Guide Magazine and the LA bureau chief for the weekly TV trade publication Electronic Media.
During my years as a trumpeter and conductor, I have seen a lot of styles of music come and go. This includes a variety of jazz, swing, and funk styles. I have also seen musicians from many different countries perform. Some of these performers were talented, while others were not. However, one style of music that I have enjoyed hearing is TAKEOFF FREESTYLE.
HISTORY of Takeoff Freestyle: Takeoff was one of the founding members of the rap trio Migos. During their time together, the group released a series of hits including "Versace" and "Bad and Boujee".
Takeoff was one of the quieter stars in Migos, but he worked hard to develop his skills and sharpen his rapping style. As a result, he is listed as a lyricist on nearly all of the group's tracks.
The group's breakout song was "Versace," which blew up after the release of the single. Takeoff also performed on the track with Quavo. Takeoff's voice was deeper and had a baritone similar to an old bluesman.
Takeoff's solo album, "The Last Rocket," was released in November. The album received acclaim from critics and listeners. It debuted at #4 on the U.S. Billboard 200.
The group's breakup came about after tensions within the group. Migos were known for their party-rapping style, and often got characterized as lowbrow mercenaries. They were also known for their Top 10 hits with Drake and Nicki Minaj. In addition to these hits, Migos also made the Top 10 with Cardi B.
Takeoff is a cousin of Quavo and his uncle Offset. They were born in Lawrenceville, Georgia. They were both raised by their mother Edna. The trio began rapping at a young age. They stayed up all night making songs for the group.
Takeoff is also a cousin of rapper Dream Doll. He was romantically linked to Lakeya Darshay. He also had a relationship with Rubi Rose.
Takeoff released his last album, "The Last Rocket," in November. He was also praised for his work on the duo album "Only Built for Infinity Links" with Quavo. The album debuted at #4 on the U.S. Top Rap Albums chart.
After Takeoff's death, a moment of silence was held for him. In addition, rapper 50 Cent announced a moment of silence. He also displayed photos of Takeoff during his concert in Finland. Takeoff was shot in Houston early Tuesday. The Los Angeles Police Department opened an investigation. The district attorney's office declined to pursue criminal charges.
Considering that Takeoff was killed in a hail of bullets, the fact that his uncle Quavo was not involved in the aforementioned melee is a non-starter. Toss in the eminently tawdry fact that the dude was a freeloader, a lot of attention is likely to be thrown at his family and entourage. Hopefully this will be a one sided affair, and we will all reclaim our tuxedos for good. This is a sad state of affairs for a guy whose music tastes could be described as a well oiled machine. Regardless of the etiquette, Takeoff's execs will be on their guard for the foreseeable future. Hopefully this will be averted with a little luck and some elbow grease. In the interim, we will all do our part to make a better you.
dr soon shiong is one of the leading scientists involved in the research and development of N-803 and COVID-19, two vaccines that are being developed to fight cancer. He is also co-founder and CEO of AccuRadio, a company that is backed by Sorrento Therapeutics. He has also been awarded a grant from the National Institute of Health to develop a vaccine to combat cancer. He is also part of the QUILT 3032 study, which is looking into the effectiveness of a combined therapy of a combination of two vaccines against cancer.
IL-15 superagonist complex, N-803 is the first immunotherapy to be approved by the FDA. The drug was approved for use in patients with non-muscle invasive bladder cancer. N-803 activates NK and T cells to attack cancer. It is currently being studied in clinical trials for other indications with a high unmet medical need.
ImmunityBio, Inc. is the parent company of N-803. The company has been awarded Breakthrough Therapy designation by the FDA. The goal of the company is to develop long-term durable remissions in cancer and infectious disease. The company has several cell therapies and vaccines under development.
The company's first BLA was submitted to the FDA in May of this year. The BLA submission is based on the results of the QUILT 3.032 trial. The trial included patients who had relapsed on checkpoint therapy for lung cancer. The combined safety analysis of the cohorts showed no treatment-related severe adverse events. The company plans to initiate registration trials for patients with recurrent or metastatic cancer.
The company also plans to submit for a BLA for advanced TNBC and pancreatic cancer. The company hopes to replace high-dose chemotherapy with immunotherapy. The company has been working on 27 clinical trials.
The company has been studying the safety and efficacy of N-803 for more than three years. N-803 is designed to have a longer persistence in lymphoid tissues. It also has improved pharmacokinetic properties.
N-803 was approved by the FDA in July of 2018. The company has also received a fast-track designation from the FDA. N-803 is being studied in clinical trials for non-small cell lung cancer, BCG-responsive bladder cancer, and other indications with a high unmet need.
Despite the recent news that the resurgence of the coronavirus isn't going away, there are still dozens of vaccine candidates advancing through Phase 3 trials worldwide. Those vaccines could one day confer long-lasting immune memory against the virus.
Currently, over half of the world's population has been fully vaccinated against the Covid-19 virus. However, many people in low-income countries are still not fully protected. This is particularly true of patients with cancer, who are at high risk. In response, pharmaceutical firms have been working to bridge the gap between the rich and poor countries' access to vaccines.
Soon-Shiong has been applying a variety of resources to his research on COVID-19. His recent announcement that he will open a vaccine plant in Cape Town, South Africa, is a major step in his effort to manufacture COVID-19 shots for the developing world. His company, ImmunityBio, has also been working on adenovirus, the virus that causes the common cold.
Soon-Shiong hopes to produce billions of doses to combat the COVID-19 virus. He plans to transfer bioreactors from US factories to a new plant in South Africa. He hopes to start Phase 2 trials of the vaccine in the first quarter of 2021. He hopes his work will contribute to more effective response preparedness in the future.
He also plans to establish a clinical trial in the United States. He plans to enroll 485,000 health workers in a trial of a COVID-19 vaccine candidate. His company's study boosts T-cell responses against the nucleocapsid, a type of virus that can cause disease. He plans to establish partnerships with companies including Amyris, Inc., Infectious Disease Research Institute and Baylor College of Medicine.
QUILT 3032 is an open-label, multicenter Phase 3 study of the company's lead product, N-803, a high-affinity, off-the-shelf NK cell infusion, delivered with BCG. In addition to providing the highest complete remission rate in its clinical trial to date, the company's product also boasts the highest median overall survival.
N-803 is the first FDA-approved immunotherapy since BCG in 1990. Intravenous BCG administration is considered the gold standard of adjuvant immunotherapy for NMIBC. In addition to triggering the innate immune system, BCG has also been shown to induce natural killer (NK) cells. This is important because NK cells are key in destroying pancreatic cancer.
As for the QUILT 3032 study, the company has completed a two-cohort study involving 160 patients. Compared to a control group, the QUILT 3032 study demonstrated a more than doubled median overall survival rate in addition to a more than 50 percent increase in median response duration for patients who failed prior therapies.
The company has also filed a Biologics License Application (BLA) for its product, N-803, with the FDA. The company has 171 subjects in its bladder cancer trials, including a Phase 3 trial. The BLA submission is based on data from the two cohorts. The study will have a priority review and a PDUFA date in 2022.
The company also released a press release containing statements regarding its clinical trials and regulatory review process. Its product candidate might be the key to a new treatment option for bladder cancer.
In addition to receiving the Breakthrough Therapy designation, the company is also on the Fast Track for its novel product. Among its product candidates are IL-15 superagonist and an adenovirus vaccine platform.
Founded in 2000 as an experimental radio station, AccuRadio is one of the early pioneers of online radio. Today, AccuRadio features over 1,100 channels of music, curated by human music lovers. AccuRadio also offers apps for iOS, Android, and Roku. AccuRadio also works with former broadcast radio personalities. It has the largest online music audience of any online radio station. Moreover, AccuRadio is one of the few profitable online radio brands.
AccuRadio is headed by CEO Kurt Hanson, and COO John Gehron. AccuRadio is available on Roku, webOS, and iOS, and has more than half a million downloads. AccuRadio was two time winner of the Webby Awards' "People's Voice" award for best radio. The company has a loyal audience, is profitable, and is a leader in customer satisfaction.
In September 2014, NantWorks LLC invested US$2.5 million into AccuRadio. Soon-Shiong has also invested in other companies, including Wibbitz, which provides automated news. He has also invested in clean-tech ventures, such as a solar-powered vehicle. In 2010, he invested in the Los Angeles Lakers, purchasing a minority stake from Magic Johnson. Soon-Shiong also purchased the San Diego Union-Tribune in a $500 million deal.
Soon-Shiong has also been a sought-after adviser for Vice President Joe Biden during the Obama administration. He has also met with President Trump at his Bedminster, NJ estate.
In 2016, Soon-Shiong launched the National Immunotherapy Coalition, which aims to improve health care through the advancement of immune therapies. Soon-Shiong has also received research awards from several medical societies.
Soon-Shiong has also served as a board member of three non-profit organizations. He is a board member of the Chan Soon-Shiong Family Foundation, which aims to fund research.
Having been a big fan of Sorrento Therapeutics (SRTN) for many years, I was curious to see what their recent announcement of three new trial sites for its SP-102 program could mean for the future of the company. After reviewing the company's filings, I was surprised to see that there are many factors that are still unknown.
The company is known for its "G-MAB(tm) library", a collection of fully human antibodies, but also has a number of other immuno-oncology platforms, including a clinical stage oncolytic virus and antibody-drug conjugates. It has also acquired a small biotech, Sofusa, in 2018 that will contribute to its multimodal approach.
The company also has an extensive pipeline of drugs. This list includes a clinical-stage oncolytic virus, several antibody-drug conjugates, and some biobetter antibodies. In the fourth quarter of 2018, Sorrento added three new trial sites. The company's SP-102 clinical trial is expected to be the crown jewel of its pipeline.
The company also has a multi-modal approach, incorporating antibody-centric and non-opioid pain therapies. A recent trial in rheumatoid arthritis is nearing completion. The company is also making strides in preclinical drug development. It also has a number of in-house manufacturing facilities. It has also launched a clinical trial for a localized lymphatic delivery system.
Despite its extensive investments, Sorrento's share price is still undervalued. For higher-risk investors, a Sorrento Therapeutics investment might be a worthwhile proposition. However, investors should be prepared for a long road ahead. It is expected that Sorrento will file for FDA approval in the coming months. As of December, Sorrento had approximately $23.3 million in gross proceeds from its offering, which was made through a registered direct offering.
Inventor of Abraxane, a drug used in the treatment of cancer, Chinese-South African transplant surgeon Patrick Soon-Shiong is a billionaire businessman, media proprietor and bioscientist. He is also the founder of the Soon-Shiong Foundation, an independent non-profit organization which aims to improve the health of children.
Known as the man behind Abraxane, Patrick Soon Shiong is a Chinese-South African transplant surgeon who is credited with inventing a drug that has been used to fight cancer. Patrick Soon Shiong has also pioneered a new therapy for diabetes, which is known as an encapsulated human islet cell transplant.
Soon-Shiong was the chief executive of two companies in the late 1990s, American Pharmaceutical Partners (APP) and American BioScience. Soon-Shiong merged the two companies and created a company that became a publicly traded company. Soon-Shiong owned a majority of the company. When the company was acquired by Fresenius Medical Care for $4.6 billion, Soon-Shiong was the largest individual shareholder.
Soon-Shiong is also the founder of VivoRx, a startup company that he co-founded with his brother. Soon-Shiong sold the company to Fresenius in 2008. Soon-Shiong was named the "American Businessman of the Year" in 2010. Soon-Shiong had a vision for cancer treatment that included network modeling of tumor genes and a personalized cocktail of cancer drugs.
Soon-Shiong's vision for cancer treatment also included supercomputing. Soon-Shiong also developed a technology to encapsulate human cells in alginic acid. Soon-Shiong performed the world's first encapsulated human islet cell transplant.
Patrick Soon Shiong's bio has been covered in several magazines and newspapers. In fact, Soon-Shiong has been featured on the 60 Minutes program. Soon-Shiong has also been honored with a Franklin Institute Award, a Vatican honor, and a Pontifical Key Visionary Award.
Soon-Shiong is an active philanthropist. He is the founder and chairman of the Chan Soon-Shiong Family Foundation and the Chan Soon-Shiong Institute for Advanced Health. He serves on the Board of Councilors of the USC Viterbi School of Engineering and is an Executive Director of the UCLA Wireless Health Institute. Soon-Shiong is a Fellow of the American College of Surgeons and the Royal College of Surgeons of Canada.
Despite his humble beginnings, Soon Shiong has become a world-renowned medical researcher. He has developed drugs to fight breast cancer, is working to eradicate TB, and has pioneered therapies for diabetes. Soon Shiong's success is also attributed to his hard work.
He was born in Port Elizabeth, South Africa, and is of ethnic Chinese heritage. His parents were refugees from China during World War II. He received a medical degree from the University of the Witwatersrand in Johannesburg, South Africa. He continued his studies in the U.S. and Canada before joining UCLA. He was recruited as an assistant professor in 1983.
Soon Shiong is a surgeon. He is also an investor, a businessman, and a philanthropist. His net worth is estimated at $11.8 billion. He is part owner of the Los Angeles Lakers. He is also chairman of the Chan Soon-Shiong Family Foundation. He and his wife, Michelle Chan, are the founders of a family foundation.
Soon Shiong was a medical researcher and inventor. His work has not been without controversy. He developed a treatment for diabetes and has also performed the first transplant of human islet cells. Soon Shiong's work also has led to accusations of price gouging, financial misrepresentation, and fraud. He has been the subject of several lawsuits. He is also a frequent subject of media investigations.
Soon Shiong has a large network of medical research firms. He has invested in clean-tech ventures. He is also the founder of two global pharmaceutical companies. He has also made a financial guarantee to help reopen the Martin Luther King Jr. Community Hospital. Soon Shiong has also been involved in an unsuccessful bid to purchase the Dodgers.
Known as the world's richest doctor, Patrick Soon-Shiong is an American physician, scientist, and entrepreneur. He is also the co-chairman of the CEO Council for Health and Innovation at the Bipartisan Policy Center. He is also chairman of the Chan Soon-Shiong Institute of Molecular Medicine.
Born in Port Elizabeth, South Africa, he studied medicine at the University of Witwatersrand in Johannesburg. His career took him to the University of California in Los Angeles, where he was a faculty member. Soon-Shiong also served as the director of the pancreas transplant program at UCLA. During his time at UCLA, he developed a novel method to treat diabetes. He also performed the world's first encapsulated human islet cell transplant, a breakthrough in the treatment of diabetic patients.
Soon-Shiong also developed the groundbreaking drug Abraxane, which is a treatment for advanced pancreatic cancer and metastatic breast cancer. The drug was approved by the FDA in 2005. In 2008, it was approved by the European equivalent.
Soon-Shiong is a member of the Global Advisory Board of Bank of America. He is also the Chairman and CEO of NantWorks, a biotech company. He also serves as a board member of the Chan Soon-Shiong Family Foundation. He owns a minority stake in the Los Angeles Lakers.
Soon-Shiong has more than 230 patents around the world. He is also the inventor of the iD system, which is a video-based content system that activates when a picture is detected.
He has also founded the biotech company Abraxis BioScience. In 2010, the company was purchased by Celgene for $3 billion. Soon-Shiong also owns the San Diego Union-Tribune.
He has also published more than 100 scientific papers. He has received awards, including the Franklin Institute Award and the Pontifical Key Visionary Award. He has also been honored by the Friends of the National Library of Medicine for his contributions to medicine.
Whether or not Patrick Soon-Shiong is trying to sell the Los Angeles Times is unknown. The Wall Street Journal reports that Soon-Shiong is considering selling the San Diego Union-Tribune. He also owns a 13 percent stake in Tronc, which owns the Los Angeles Times. The company has faced numerous leadership upheavals and has struggled with dwindling readership.
The Washington Post is working on a story about Soon-Shiong's influence at the LA Times. The newspaper says that most of the paper's employees are underpaid and marginalized, and most are not given opportunities for advancement.
Soon-Shiong is an entrepreneur who has made his fortune by founding and financing several companies, including NantWorks, a medical research firm, and VivoRx, a biotech company. He has also invested in clean tech ventures. Soon-Shiong is a frequent guest at the Staples Center and has connections with many Los Angeles businesses.
Soon-Shiong also owns a 4.5 percent stake in the Los Angeles Lakers. He has donated $50,000 to Hillary Clinton's campaign. He has also worked as a consultant to World Bank Group president Jim Yong Kim. Soon-Shiong also helped develop a strategy to influence big tech companies.
Soon-Shiong has received a lot of criticism over his business dealings. Some have accused him of price gouging and financial misrepresentation. He has also been sued. One of his competitors filed a billion-dollar lawsuit.
Soon-Shiong is a physician-scientist, and he has developed a series of businesses centered on medical research and clean technology. Soon-Shiong's companies have raised hundreds of millions of dollars in investments. Soon-Shiong's net worth is estimated at $8 billion as of October 2021.
Soon-Shiong has a reputation for being humble and paternal. He believes that his vision is important.
Inventor, bioscientist, and media proprietor Patrick Soon-Shiong's net worth has surpassed $10 billion. His business empire includes a home in Los Angeles, California, and stakes in media firms such as Verizon and Google. Soon-Shiong has also made his fortune in the pharmaceutical industry. He is the inventor of the pancreatic-cancer drug Abraxane, which was approved for sale in 2005. He has more than 50 patents, including more than 100 international patents. Soon-Shiong is also a philanthropist. He and his wife, Michele B. Chan, have two children together.
Soon-Shiong is a co-founder of NantWorks, a network of health startups. He also is the chairman of the Chan Soon-Shiong Family Foundation, which aims to fund research. His Cancer MoonShot 2020 effort will focus on human immune systems to control tumors. In September 2018, he invested in Daybreak Game Co., an esports business. He also owns a 4.5% stake in the Los Angeles Lakers.
Soon-Shiong is a former member of the UCLA medical school faculty. He completed his surgical training at UCLA when he was 31. He also completed an internship at a general hospital in Johannesburg, South Africa. Soon-Shiong earned his master's degree from the University of British Columbia. His parents were Chinese, who left their country during World War II. Soon-Shiong was born in Port Elizabeth, South Africa.
Soon-Shiong started his first investment fund called Genentech Capital. In 2007, he bought shares in NantHealth. Soon-Shiong owns 23,750,750 shares of NantHealth stock. He was one of the first shareholders of the company.
In July 2008, Soon-Shiong sold APP Pharmaceuticals to Fresenius SE for $4.6 billion. The company generated $750 million per year in revenue. The resulting firm became known as American Pharmaceutical Partners.